| # | Drug | Count |
|---|---|---|
| 0 | AZACITIDINE | 1 |
| 1 | CETUXIMAB | 1 |
| 2 | CISPLATIN | 1 |
| 3 | DIPHENHYDRAMINE HYDROCHLORIDE | 1 |
| 4 | DORAVIRINE, LAMIVUDINE, AND TENOFOVIR DISOPROXIL FUMARATE | 1 |
| 5 | DUPILUMAB | 1 |
| 6 | LISINOPRIL | 1 |
| 7 | MECLIZINE | 1 |
| 8 | MECLIZINE HCL 12.5 MG | 1 |
| 9 | MECLIZINE HCL 12.5MG | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DORAVIRINE, LAMIVUDINE, AND TENOFOVIR DISOPROXIL FUMARATE | 1 | 0.0032 |
| 1 | MECLIZINE HCL 12.5 MG | 1 | 0.0001 |
| 2 | MECLIZINE HYDROCHLORIDE | 1 | 0.0001 |
| 3 | AZACITIDINE | 1 | 0.0000 |
| 4 | CETUXIMAB | 1 | 0.0000 |
| 5 | CISPLATIN | 1 | 0.0000 |
| 6 | DIPHENHYDRAMINE HYDROCHLORIDE | 1 | 0.0000 |
| 7 | RITUXIMAB | 1 | 0.0000 |
| 8 | LISINOPRIL | 1 | 0.0000 |
| 9 | DUPILUMAB | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 1 | 0.0000 |
| 1 | Epidermal Growth Factor Receptor Antagonist [EPC] | 1 | 0.0000 |
| 2 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 1 | 0.0000 |
| 3 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 1 | 0.0000 |
| 4 | Opioid Agonist [EPC] | 1 | 0.0000 |
| 5 | Platinum-based Drug [EPC] | 1 | 0.0000 |
| 6 | Nucleoside Metabolic Inhibitor [EPC] | 1 | 0.0000 |
| 7 | CD20-directed Cytolytic Antibody [EPC] | 1 | 0.0000 |
| 8 | Interleukin-4 Receptor alpha Antagonist [EPC] | 1 | 0.0000 |